ID: ALA5273868

Max Phase: Preclinical

Molecular Formula: C21H16N4

Molecular Weight: 324.39

Associated Items:

Representations

Canonical SMILES:  N#Cc1ccc2ncnc(NCCc3ccc4ccccc4c3)c2c1

Standard InChI:  InChI=1S/C21H16N4/c22-13-16-6-8-20-19(12-16)21(25-14-24-20)23-10-9-15-5-7-17-3-1-2-4-18(17)11-15/h1-8,11-12,14H,9-10H2,(H,23,24,25)

Standard InChI Key:  GNPMQXLITTWHDA-UHFFFAOYSA-N

Associated Targets(Human)

CDK8/Cyclin C 1054 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 324.39Molecular Weight (Monoisotopic): 324.1375AlogP: 4.31#Rotatable Bonds: 4
Polar Surface Area: 61.60Molecular Species: NEUTRALHBA: 4HBD: 1
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 4.62CX LogP: 4.35CX LogD: 4.35
Aromatic Rings: 4Heavy Atoms: 25QED Weighted: 0.61Np Likeness Score: -1.17

References

1. Wu D, Zhang Z, Chen X, Yan Y, Liu X..  (2021)  Angel or Devil ? - CDK8 as the new drug target.,  213  [PMID:33257171] [10.1016/j.ejmech.2020.113043]

Source